195 related articles for article (PubMed ID: 6668097)
1. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
González-Martín G; Bravo I; Ibarra N; Arancibia A
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):598-601. PubMed ID: 6668097
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic study of intravenous furosemide in nephrotic syndrome in children].
Lenoir G; Halter D; Seligman R; Dreuz C
Arch Fr Pediatr; 1978 Feb; 35(2):187-97. PubMed ID: 637676
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of gentamicin in children with nephrotic syndrome.
González-Martin G; Bravo I; Vargas H; Arancibia A
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):555-8. PubMed ID: 3781676
[TBL] [Abstract][Full Text] [Related]
4. Urinary elimination kinetics and diuretic effect of intravenous furosemide in nephrotic children.
Prandota J
Dev Pharmacol Ther; 1982; 5(1-2):98-108. PubMed ID: 7151641
[TBL] [Abstract][Full Text] [Related]
5. [The effect of albumin and furosemide administration in children with primary nephrotic syndrome (author's transl)].
Rego Filho Ede A; Casoni W
Rev Bras Pesqui Med Biol; 1977; 10(5):299-304. PubMed ID: 594431
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
Prandota J
Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of orally administered furosemide in children with nephrotic syndrome].
Prandota J
Pediatr Pol; 1982; 57(9):711-8. PubMed ID: 7170150
[No Abstract] [Full Text] [Related]
8. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
[TBL] [Abstract][Full Text] [Related]
9. Disposition and diuretic effect of furosemide in the nephrotic syndrome.
Keller E; Hoppe-Seyler G; Schollmeyer P
Clin Pharmacol Ther; 1982 Oct; 32(4):442-9. PubMed ID: 7116760
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and pharmacokinetics of the basic triamterene analogue dimethylaminohydroxypropoxytriamterene.
Priewer H; Kraft H; Mutschler E
Arzneimittelforschung; 1985; 35(11):1688-91. PubMed ID: 4091871
[TBL] [Abstract][Full Text] [Related]
11. Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?
Na KY; Han JS; Kim YS; Ahn C; Kim S; Lee JS; Bae KS; Jang IJ; Shin SG; Huh W; Jeon US
J Korean Med Sci; 2001 Aug; 16(4):448-54. PubMed ID: 11511790
[TBL] [Abstract][Full Text] [Related]
12. Co-administration of albumin-furosemide in patients with the nephrotic syndrome.
Ghafari A; Mehdizadeh A; Alavi-Darazam I; Rahimi E; Kargar C; Sepehrvand N
Saudi J Kidney Dis Transpl; 2011 May; 22(3):471-5. PubMed ID: 21566302
[TBL] [Abstract][Full Text] [Related]
13. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of high dose furosemide in patients with chronic renal failure or nephrotic syndrome.
Kühnel HJ; Günther K; Stein G; Hoffmann-Traeger A
Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):616-21. PubMed ID: 3429064
[TBL] [Abstract][Full Text] [Related]
15. Patterns of potassium wasting in response to stepwise combinations of diuretics in nephrotic syndrome.
Haris A; Radó JP
Int J Clin Pharmacol Ther; 1999 Jul; 37(7):332-40. PubMed ID: 10442507
[TBL] [Abstract][Full Text] [Related]
16. [Furosemide--pharmacokinetics in geriatric patients with multimorbidity].
Neubig E; Mühlberg W; Platt D
Z Gerontol; 1984; 17(5):251-60. PubMed ID: 6523981
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients.
Nakahama H; Orita Y; Yamazaki M; Itoh S; Okuda T; Yamaji A; Miwa Y; Yanase M; Fukuhara Y; Kamada T
Nephron; 1988; 49(3):223-7. PubMed ID: 3398982
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.
Chay S; Woods WE; Rowse K; Nugent TE; Blake JW; Tobin T
Drug Metab Dispos; 1983; 11(3):226-31. PubMed ID: 6135581
[TBL] [Abstract][Full Text] [Related]
19. Diuretic effect and duration of action of a single intravenous dose of furosemide in uremia and myocardial infarction.
Farghali H; Al Zuhair H; Al Windawi S; Al Hamdi A; Fariduddin M
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):659-64. PubMed ID: 6526541
[TBL] [Abstract][Full Text] [Related]
20. Role of binding in distribution of furosemide: where is nonrenal clearance?
Branch RA
Fed Proc; 1983 Apr; 42(6):1699-702. PubMed ID: 6832389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
